Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
11
Number of overlapping holdings
26.8%
% of GNOM's 41 holdings also in FBT
36.7%
% of FBT's 31 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
ULTRAGENYX PHARMACEUTICAL IN | 3.8% | 3.8% | 3.8% |
|
QIAGEN NV | 3.6% | 3.6% | 3.6% |
|
BIOMARIN PHARMACEUTICAL INC | 3.5% | 3.6% | 3.5% |
 |
BIONTECH SE SPONSORED ADR | 3.3% | 3.6% | 3.3% |
|
ALNYLAM PHARMACEUTICALS INC | 3.3% | 3.3% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to FBT
 |
ENI SPA-SPONSORED ADR | 7.5% |
|
CRISPR THERAPEUTICS AG | 5.8% |
|
NATERA INC | 4.4% |
|
INTELLIA THERAPEUTICS, INC. | 4.0% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 3.9% |
|
AGILENT TECHNOLOGIES INC | 3.9% |
|
10X GENOMICS INC CLASS A | 3.8% |
 |
GENSCRIPT BIOTECH CORPORATION | 3.7% |
|
PACIFIC BIOSCIENCES OF CALIF | 3.7% |
|
BEAM THERAPEUTICS, INC. | 3.6% |
GNOM Underweight Relative to FBT
 |
GRIFOLS SA-ADR | -3.9% |
|
IQVIA HOLDINGS INC | -3.7% |
|
IONIS PHARMACEUTICALS, INC. | -3.5% |
 |
GENMAB A/S SPONSORED ADR | -3.5% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.5% |
|
CHARLES RIVER LABORATORIES | -3.5% |
 |
ARGENX SE ADR | -3.4% |
|
AGIOS PHARMACEUTICALS INC | -3.4% |
|
UNITED THERAPEUTICS CORP | -3.4% |
|
EXELIXIS INC | -3.4% |